SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-20-006060
Filing Date
2020-03-12
Accepted
2020-03-12 07:59:17
Documents
54
Period of Report
2020-03-12
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea119536-8k_bioxytraninc.htm 8-K 17330
2 BIOXYTRAN, INC. PRESENTATION, DATED MARCH 12, 2020 ea119536ex99-1_bioxytran.htm EX-99.1 55267
3 GRAPHIC ex99-1_001.jpg GRAPHIC 312405
4 GRAPHIC ex99-1_002.jpg GRAPHIC 233659
5 GRAPHIC ex99-1_003.jpg GRAPHIC 305458
6 GRAPHIC ex99-1_004.jpg GRAPHIC 67807
7 GRAPHIC ex99-1_005.jpg GRAPHIC 191476
8 GRAPHIC ex99-1_006.jpg GRAPHIC 191929
9 GRAPHIC ex99-1_007.jpg GRAPHIC 130532
10 GRAPHIC ex99-1_008.jpg GRAPHIC 170758
11 GRAPHIC ex99-1_009.jpg GRAPHIC 268640
12 GRAPHIC ex99-1_010.jpg GRAPHIC 287669
13 GRAPHIC ex99-1_011.jpg GRAPHIC 159169
14 GRAPHIC ex99-1_012.jpg GRAPHIC 257679
15 GRAPHIC ex99-1_013.jpg GRAPHIC 283805
16 GRAPHIC ex99-1_014.jpg GRAPHIC 195322
17 GRAPHIC ex99-1_015.jpg GRAPHIC 322315
18 GRAPHIC ex99-1_016.jpg GRAPHIC 188408
19 GRAPHIC ex99-1_017.jpg GRAPHIC 176839
20 GRAPHIC ex99-1_018.jpg GRAPHIC 163639
21 GRAPHIC ex99-1_019.jpg GRAPHIC 245358
22 GRAPHIC ex99-1_020.jpg GRAPHIC 119628
23 GRAPHIC ex99-1_021.jpg GRAPHIC 182414
24 GRAPHIC ex99-1_022.jpg GRAPHIC 147942
25 GRAPHIC ex99-1_023.jpg GRAPHIC 253392
26 GRAPHIC ex99-1_024.jpg GRAPHIC 246601
27 GRAPHIC ex99-1_025.jpg GRAPHIC 139863
28 GRAPHIC ex99-1_026.jpg GRAPHIC 135626
29 GRAPHIC ex99-1_027.jpg GRAPHIC 251238
30 GRAPHIC ex99-1_028.jpg GRAPHIC 64089
31 GRAPHIC ex99-1_029.jpg GRAPHIC 128045
32 GRAPHIC ex99-1_030.jpg GRAPHIC 180915
33 GRAPHIC ex99-1_031.jpg GRAPHIC 220776
34 GRAPHIC ex99-1_032.jpg GRAPHIC 275600
35 GRAPHIC ex99-1_033.jpg GRAPHIC 192703
36 GRAPHIC ex99-1_034.jpg GRAPHIC 233823
37 GRAPHIC ex99-1_035.jpg GRAPHIC 161264
38 GRAPHIC ex99-1_036.jpg GRAPHIC 244617
39 GRAPHIC ex99-1_037.jpg GRAPHIC 315108
40 GRAPHIC ex99-1_038.jpg GRAPHIC 273444
41 GRAPHIC ex99-1_039.jpg GRAPHIC 234337
42 GRAPHIC ex99-1_040.jpg GRAPHIC 300219
43 GRAPHIC ex99-1_041.jpg GRAPHIC 242302
44 GRAPHIC ex99-1_042.jpg GRAPHIC 244045
45 GRAPHIC ex99-1_043.jpg GRAPHIC 205642
46 GRAPHIC ex99-1_044.jpg GRAPHIC 237804
47 GRAPHIC ex99-1_045.jpg GRAPHIC 246238
48 GRAPHIC ex99-1_046.jpg GRAPHIC 287887
49 GRAPHIC ex99-1_047.jpg GRAPHIC 275348
50 GRAPHIC ex99-1_048.jpg GRAPHIC 304309
51 GRAPHIC ex99-1_049.jpg GRAPHIC 169597
52 GRAPHIC ex99-1_050.jpg GRAPHIC 270879
53 GRAPHIC ex99-1_051.jpg GRAPHIC 287087
54 GRAPHIC ex99-1_052.jpg GRAPHIC 403854
  Complete submission text file 0001213900-20-006060.txt   16098230
Mailing Address C/O BIOXYTRAN, INC. 233 NEEDHAM ST, SUITE 300 NEWTON MA 02464
Business Address C/O BIOXYTRAN, INC. 233 NEEDHAM ST, SUITE 300 NEWTON MA 02464 617-494-1199
BIOXYTRAN, INC (Filer) CIK: 0001445815 (see all company filings)

IRS No.: 262797630 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35027 | Film No.: 20707188
SIC: 2834 Pharmaceutical Preparations